Skip header and navigation

Refine By

27 records – page 1 of 3.

[Access to case records at Aalborg Psychiatric Hospital 1 March 1987-29 February 1988. A prospective study]

https://arctichealth.org/en/permalink/ahliterature12182
Source
Ugeskr Laeger. 1990 May 21;152(21):1528-31
Publication Type
Article
Date
May-21-1990
Author
E. Høyer
I. Kattrup
P B Christensen
Author Affiliation
Aalborg Psykiatriske Sygehus, afsnit R og S.
Source
Ugeskr Laeger. 1990 May 21;152(21):1528-31
Date
May-21-1990
Language
Danish
Publication Type
Article
Keywords
Adult
Aged
Denmark
English Abstract
Hospital Records - legislation & jurisprudence
Hospitals, Psychiatric
Humans
Legislation, Medical - trends
Male
Mental Disorders - diagnosis
Middle Aged
Patient Advocacy - legislation & jurisprudence
Prospective Studies
Psychiatry - legislation & jurisprudence
Abstract
The purpose of the investigation was to examine the utilization of the Danish legislation concerning access to case records by means of a prospective registration and questionnaire. During the investigation-period (1.3.1987-29.02.1988) 50 requests were made of which only one was refused for a limited period. The patients requesting to read their records differed from the total population of hospitalized patients as regards diagnosis as significantly more schizofrenic and fewer patients with diagnoses of drug abuse, were found. One of the 32 patients who actually read their records became more psychotic afterwards and two patients stated that they had become agitated. However, 15 patients felt calmer and 29 patients (90.6%) stated that the purpose of requesting access to their records had been fulfilled. The overall impression is that the law, which came into effect 1.1.1987, has functioned adequately although a more restrictive attitude would perhaps have reduced the negative influence on the psychotic conditions observed in three patients.
PubMed ID
2360272 View in PubMed
Less detail
Source
Acta Neurol Scand. 1996 Feb-Mar;93(2-3):156-9
Publication Type
Article
Author
B. Sivertsen
P B Christensen
Author Affiliation
Department of Neurology, Aarhus Kommunehospital, Denmark.
Source
Acta Neurol Scand. 1996 Feb-Mar;93(2-3):156-9
Language
English
Publication Type
Article
Keywords
Acute Disease
Adolescent
Adult
Aged
Child
Child, Preschool
Denmark - epidemiology
Diagnosis, Differential
Encephalitis - diagnosis - etiology - mortality
Female
Humans
Male
Middle Aged
Neurologic Examination
Survival Rate
Abstract
Acute encephalitis: etiology, clinical findings and prognosis. We studied 44 patients with acute encephalitis diagnosed in a neurological university clinic during an 11-year period. An etiology was found in 11 cases (25%). In 3 the cause was herpes simplex virus; in 2 morbilli. There were single patients in which the cause was mycoplasma pneumoniae, epidemic parotitis, ornithosis, infectious mononucleosis, influenza B-virus and recent tetanus immunization. No specific etiology was found in 33 (75%). Besides fever the most frequent sign was impairment of consciousness in 39% of cases. Four patients (9%) died. Among the survivors mental and/or focal neurological deficits persisted in 22 (55%). Most frequent was dementia in 6 cases (15% of survivors). Impaired consciousness in the acute phase indicated a worse prognosis (p
PubMed ID
8741136 View in PubMed
Less detail

Adenocarcinoma of the esophagus and Barrett's esophagus: a population-based study.

https://arctichealth.org/en/permalink/ahliterature21261
Source
Am J Gastroenterol. 1999 Jan;94(1):86-91
Publication Type
Article
Date
Jan-1999
Author
P. Bytzer
P B Christensen
P. Damkier
K. Vinding
N. Seersholm
Author Affiliation
The Department of Medical Gastroenterology S, Odense University Hospital, and Danish Cancer Society, Copenhagen.
Source
Am J Gastroenterol. 1999 Jan;94(1):86-91
Date
Jan-1999
Language
English
Publication Type
Article
Keywords
Adenocarcinoma - complications - diagnosis - epidemiology
Aged
Barrett Esophagus - complications
Carcinoma, Squamous Cell - complications - epidemiology
Denmark - epidemiology
Esophageal Neoplasms - complications - diagnosis - epidemiology
Female
Humans
Incidence
Male
Middle Aged
Stomach Neoplasms - complications - epidemiology
Abstract
OBJECTIVE: We described incidence rates of esophageal adenocarcinoma in Denmark in a 20-yr period and determined the proportion of patients diagnosed with esophageal adenocarcinoma who had a previous diagnosis of Barrett's esophagus, making them potential candidates for endoscopic surveillance. METHODS: Rates of esophageal and gastric cancers were collected from the Danish Cancer registry for the period 1970-1991. The registry was used to identify all cases of esophageal adenocarcinoma in the period 1987-1992. Medical records were retrieved and details concerning previous diagnosis of reflux disease and Barrett's esophagus were recorded. RESULTS: The age- and gender-adjusted incidence of esophageal adenocarcinoma increased eightfold, from 0.3/10(5)/yr in 1970 to 2.3/10(5)/yr in 1990. This increase could not be explained by changes in classification or diagnostic routines. Medical data were retrieved for 524 of the 578 cases of esophageal adenocarcinoma reported during the period 1987-1992. A history of reflux symptoms or a diagnosis compatible with reflux was reported in 113 of 524 patients. A total of 119 patients (23%) had previously been investigated for dyspepsia or reflux symptoms, most often by endoscopy. A previous diagnosis of Barrett's esophagus was found in only 1.3% of the cancer patients. CONCLUSIONS: The rate of esophageal adenocarcinoma in Denmark has increased eightfold over a 20-yr period, and this increase is not explained by changes in classification or diagnostic routines. More than 98% of esophageal adenocarcinomas were found in patients who could not have entered endoscopic surveillance, as Barrett's esophagus had not been diagnosed before the cancer diagnosis. Endoscopic surveillance to detect dysplasia may be an option for the individual patient with Barrett's esophagus, but these screening programs are not likely to reduce the death rate from esophageal adenocarcinomas in the general population.
PubMed ID
9934736 View in PubMed
Less detail

Associated autoimmune diseases in myasthenia gravis. A population-based study.

https://arctichealth.org/en/permalink/ahliterature14342
Source
Acta Neurol Scand. 1995 Mar;91(3):192-5
Publication Type
Article
Date
Mar-1995
Author
P B Christensen
T S Jensen
I. Tsiropoulos
T. Sørensen
M. Kjaer
E. Højer-Pedersen
M J Rasmussen
E. Lehfeldt
Author Affiliation
Department of Neurology, Aarhus University Hospital, Denmark.
Source
Acta Neurol Scand. 1995 Mar;91(3):192-5
Date
Mar-1995
Language
English
Publication Type
Article
Keywords
Arthritis, Rheumatoid - complications - epidemiology
Denmark - epidemiology
Female
Humans
Male
Middle Aged
Myasthenia Gravis - complications - epidemiology
Prevalence
Prognosis
Retrospective Studies
Severity of Illness Index
Thymectomy
Thymoma - complications - epidemiology - surgery
Thymus Neoplasms - complications - epidemiology - surgery
Thyroid Diseases - complications - epidemiology
Abstract
During a comprehensive epidemiological study of myasthenia gravis (MG) in Western Denmark 1975-1989, we analyzed the occurrence, clinical characteristics and prognosis of associated autoimmune diseases (AAD) in MG patients. AAD were found in 20 of 212 incident cases (9%) and in 30 of 220 prevalent cases (14%). The most common diseases were: thyroid disorders and rheumatic arthritis. Clinically, it was not possible to identify a subgroup of MG patients with a higher risk of AAD. In most MG patients the AAD occurred before thymectomy. The severity of the AAD was not influenced by thymectomy. The remission rate was lower in MG patients with AAD than in MG patients without AAD suggesting that the autoimmune response in MG patients with AAD is more severe.
Notes
Comment In: Acta Neurol Scand. 1995 Dec;92(6):503-48750118
PubMed ID
7793234 View in PubMed
Less detail

[Cerebellar tuberculoma. A rare case in an industrialized community]

https://arctichealth.org/en/permalink/ahliterature39519
Source
Ugeskr Laeger. 1985 Jul 15;147(29):2349-50
Publication Type
Article
Date
Jul-15-1985

Cerebellar tuberculoma: a rare disease in an industrialized country.

https://arctichealth.org/en/permalink/ahliterature39631
Source
Childs Nerv Syst. 1985;1(5):295-7
Publication Type
Article
Date
1985
Author
J. Haase
P B Christensen
K. Kock
H M Ingstrup
Source
Childs Nerv Syst. 1985;1(5):295-7
Date
1985
Language
English
Publication Type
Article
Keywords
Cerebellar Diseases - diagnosis - drug therapy - radiography - surgery
Child
Drug Therapy, Combination
Ethambutol - therapeutic use
Humans
Isoniazid - therapeutic use
Male
Rifampin - therapeutic use
Tuberculoma - diagnosis - drug therapy - radiography - surgery
Abstract
A nine-year-old Somalian boy was treated in Denmark for a posterior fossa tumor, which proved to be a tuberculoma. This disease is virtually unknown in our highly industrialized country, which emphasizes the fact that due to increased international traveling, knowledge of endemic diseases in other parts of the world is necessary. The treatment of tuberculoma and their diagnostic features are reviewed.
PubMed ID
4084914 View in PubMed
Less detail

Decline in hepatitis B infection observed after 11 years of regional vaccination among Danish drug users.

https://arctichealth.org/en/permalink/ahliterature100421
Source
J Med Virol. 2010 Oct;82(10):1635-9
Publication Type
Article
Date
Oct-2010
Author
B K Mössner
M. Skamling
T Riis Jørgensen
J. Georgsen
C. Pedersen
P B Christensen
Author Affiliation
Department of Infectious Diseases, Odense University Hospital, Odense, Denmark. belinda.klemmensen@gmail.com
Source
J Med Virol. 2010 Oct;82(10):1635-9
Date
Oct-2010
Language
English
Publication Type
Article
Keywords
Adult
Cross-Sectional Studies
Denmark - epidemiology
Drug users
Female
HIV Antibodies - blood
Hepacivirus - isolation & purification
Hepatitis B - epidemiology - prevention & control
Hepatitis B Antibodies - blood
Hepatitis B Surface Antigens - blood
Hepatitis B Vaccines - administration & dosage - immunology
Hepatitis C Antibodies - blood
Humans
Male
Middle Aged
Prevalence
RNA, Viral - blood
Substance-Related Disorders - complications
Abstract
The aims of this study were to determine the current prevalence of viral hepatitis and HIV among drug users, and to compare this prevalence with previous findings in the same geographical region. Cross-sectional surveys of drug users attending treatment centers on the island of Funen with approximately 500,000 inhabitants were administered in 1996 and 2007. The 2007 prevalence estimates were: anti-HBc 50.2%, HBsAg 0.9%, anti-HCV 66.8%, HCV-RNA 40%, and anti-HIV 1.1%. The corresponding 1996 prevalence values were: anti-HBc 70% (P?
PubMed ID
20827758 View in PubMed
Less detail

[Delays in admissions for observation in suspected acute myocardial infarction]

https://arctichealth.org/en/permalink/ahliterature54983
Source
Ugeskr Laeger. 1993 Sep 13;155(37):2892-6
Publication Type
Article
Date
Sep-13-1993
Author
J. Jensen
P B Christensen
Author Affiliation
Medicinsk afdeling, Nyborg Sygehus.
Source
Ugeskr Laeger. 1993 Sep 13;155(37):2892-6
Date
Sep-13-1993
Language
Danish
Publication Type
Article
Keywords
Adult
Aged
Decision Making
Denmark
English Abstract
Female
Humans
Male
Middle Aged
Myocardial Infarction - diagnosis - therapy
Patient Admission
Prospective Studies
Referral and Consultation
Time Factors
Transportation of Patients
Abstract
One hundred and fifty-three patients hospitalized for observation and treatment of suspected acute myocardial infarction (AMI) were studied. The time delay from debut of symptoms until the decision was taken as to whether the patient was a candidate for treatment with thrombolysis or not was registered. The decision was made within four hours for 55.5% of the patients, and for 81.0% the decision was made within 12 hours of debut of symptoms. In all, 47 (30.1%) of the patients were treated with thrombolysis. Fifty-six (36.6%) of the patients had an AMI or unstable angina pectoris, and 39 (69.6%) were treated with thrombolysis. Seventeen patients with AMI did not receive the treatment, and for one of these the only reason for not receiving thrombolysis was a time delay longer than 12 hours. The median time for patient delay was 60 minutes, doctors' delay 39 minutes, and transport delay 29 min. At the hospital the first ECG was done 14 minutes after arrival, and the decision about whether to treat with thrombolysis or not was taken 25 minutes after arrival. It is still possible to diminish the time delays for patients suspected of AMI. The longest delay is due to the patient, and public education is needed to minimize patient delay. Doctors are recommended to refer patients suspected of AMI directly to the hospital, omitting a delaying visit to the patient.
PubMed ID
8259616 View in PubMed
Less detail
Source
Ugeskr Laeger. 1998 Jun 8;160(24):3529-32
Publication Type
Article
Date
Jun-8-1998
Author
P B Christensen
Author Affiliation
Odense Universitetshospital, klinisk immunologisk afdeling. peer.christensen@ouh.dk
Source
Ugeskr Laeger. 1998 Jun 8;160(24):3529-32
Date
Jun-8-1998
Language
Danish
Publication Type
Article
Keywords
Denmark - epidemiology
Hepatitis C - epidemiology
Humans
Incidence
Prevalence
PubMed ID
9641037 View in PubMed
Less detail

Hepatitis B core antibodies in Danish blood donors: a surrogate marker of risk behaviour.

https://arctichealth.org/en/permalink/ahliterature52288
Source
Vox Sang. 2001 Nov;81(4):222-7
Publication Type
Article
Date
Nov-2001
Author
P B Christensen
I L Titlestad
K M Homburg
J. Georgsen
T. Kristensen
Author Affiliation
Department of Clinical Immunology, Odense University Hospital, DK 5000 Odense C, Denmark. peer.christensen@dadlnet.dk
Source
Vox Sang. 2001 Nov;81(4):222-7
Date
Nov-2001
Language
English
Publication Type
Article
Keywords
Adult
Biological Markers - blood
Blood Donors - classification - psychology
Blood-Borne Pathogens
Denmark - epidemiology
Female
Hepatitis B Antibodies - blood
Hepatitis B Core Antigens - immunology
Humans
Male
Middle Aged
Prevalence
Questionnaires
Research Support, Non-U.S. Gov't
Risk factors
Risk-Taking
Sexually transmitted diseases
Abstract
BACKGROUND AND OBJECTIVES: The aim of this work was to determine the prevalence of antibodies to hepatitis B core antigen (anti-HBc) among Danish blood donors and to correlate this with risk factors for blood-borne and sexually transmitted diseases. MATERIALS AND METHODS: During a 5-month period, 10 862 consecutive donors in the County of Funen were screened for anti-HBc, and repeat-reactive samples were confirmed by supplementary testing. Information on risk factors was assessed by questionnaire in 585 consecutive anti-HBc-negative blood donors and compared with information obtained from confirmed positive donors. RESULTS: The prevalence of confirmed positive anti-HBc among donors was 0.70% (76/10 862, 95% confidence interval [CI]: 0.55-0.87). One donor was positive for anti-HBc immunoglobulin M (IgM); none tested positive for hepatitis B virus (HBV) DNA. In a logistic regression analysis, age, female gender, tattoos and commercial sexual relations, were independent predictive factors for the presence of anti-HBc. CONCLUSION: Anti-HBc is a surrogate marker for previous risk behaviour in the Danish blood donor population. We suggest that screening for anti-HBc may be used among new donors to supplement interviews on risk behaviour.
Notes
Comment In: Vox Sang. 2002 Apr;82(3):161; author reply 16111952992
PubMed ID
11903997 View in PubMed
Less detail

27 records – page 1 of 3.